NCT06940063 Active Music-Based Intervention in Patients With Chronic Low Back Pain
| NCT ID | NCT06940063 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sharon Wang-Price |
| Condition | Chronic Low Back Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-08-07 |
| Primary Completion | 2027-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-08-07 with a primary completion date of 2027-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if active music-based intervention works to treat patients with chronic low back pain. The main questions it aims to answer are: 1. Does active music-based intervention improve cognitive function? 2. Does active music -based intervention improve sensitivity to stimuli? 3. Does active music-based intervention improve pain catastrophizing behavior? 4. Does active music-based intervention improve quality of life? Participant will visit the clinic for 5 sessions of assessments and active music-based intervention over 2 weeks. On the first visit, it will take each participant 45 minutes to complete the pre-intervention assessments followed by a 45-minute active music-based intervention. The active music-based intervention will last about an hour for the remaining 4 visits. On the 5th or last visit, after the one-hour intervention, it will take another 30 minutes for each participant to complete the post-intervention assessments.
Eligibility Criteria
Inclusion Criteria: * adults 18-65 years of age * have chronic low back pain (CLBP) primarily in the L4-5 area. The CLBP is defined as a back pain problem that has persisted at least 3 months and has resulted in pain on at least half the days in the past 6 months. Exclusion Criteria: Participants will be excluded if their low back pain (LBP) is due to a non-musculoskeletal origin or they have any medical conditions that may affect the results: * Previous back surgery * Systemic arthritis (e.g., rheumatoid arthritis, psoriatic arthritis). * Fracture of thoracic and lumbar spine, pelvis * Infection * Tumor * Traumatic brain injury * Stroke * Seizures/epilepsy * Any other neurological disease (e.g., multiple sclerosis, muscular dystrophy, - Parkinson's) * Circulation/vascular problems (e.g., Raynaud's) * Cancer * Uncontrolled diabetes/high blood sugar * Currently pregnant
Contact & Investigator
Sharon Wang-Price, PhD
PRINCIPAL INVESTIGATOR
Texas Woman's University
Frequently Asked Questions
Who can join the NCT06940063 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Chronic Low Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06940063 currently recruiting?
Yes, NCT06940063 is actively recruiting participants. Contact the research team at swang@twu.edu for enrollment information.
Where is the NCT06940063 trial being conducted?
This trial is being conducted at Denton, United States.
Who is sponsoring the NCT06940063 clinical trial?
NCT06940063 is sponsored by Sharon Wang-Price. The principal investigator is Sharon Wang-Price, PhD at Texas Woman's University. The trial plans to enroll 40 participants.